Skip to main content
Premium Trial:

Request an Annual Quote

Raynard Kington, Elias Zerhouni, Michael Berens, MaryAnn Guerra

Raynard Kington has become acting director of the National Institutes of Health, following the departure of Elias Zerhouni on Oct. 31. Kington has taken over the post until a new director is appointed after the US presidential elections. He has served as Zerhouni’s deputy since 2003. Prior to that, he was associate director of NIH for behavioral and social sciences research.

The Arizona Technology Council has appointed Michael Berens and MaryAnn Guerra of the Translational Genomics Research Institute to its board of directors. Berens, who was appointed chairman emeritus of the board, is the director of the cancer and cell biology division at TGen. Guerra is TGen’s chief business officer.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.